Detection of VEGF in patients with colorectal cancer and its clinical significance
Dong Jian
Abstract
Dong Jian
Abstract
Objective To investigate serum levels of vascular endothelial growth factor(VEGF) in patients with colorectal cancer and its clinical significance.Methods Serum VEGF levels were detected by enzyme-linked immunosorbent assay(ELISA) in 64 patients with colorectal cancer 48healthy subjects.Results The serum VEGF levels of colorectal cancer patients were higher than those of healthy controls(t=34.11,P0.05).Among patients with colorectal cancer serum VEGF levels in those with lymph node metastasis were higher than those without lymph node metastasis(P0.05);VEGF levels in those with liver metastasis were higher than those without liver metastasis(P0.05);and VEGF levels in patients with TNM stage Ⅰ,Ⅱ,Ⅲ and Ⅳ were(120.14±25.88),(192.07±26.95),(77.93±63.18)and(433.40±48.39)pg/ml,respectively(F=83.11,P0.05).Conclusion Serum VEGF levels are increased in patients with colorectal cancer and related to lymph node metastasis,liver metastasis and TNM stages,indicating it might be used as a biomarker for colorectal cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate serum levels of vascular endothelial growth factor(VEGF) in patients with colorectal cancer and its clinical significance.Methods Serum VEGF levels were detected by enzyme-linked immunosorbent assay(ELISA) in 64 patients with colorectal cancer 48healthy subjects.Results The serum VEGF levels of colorectal cancer patients were higher than those of healthy controls(t=34.11,P0.05).Among patients with colorectal cancer serum VEGF levels in those with lymph node metastasis were higher than those without lymph node metastasis(P0.05);VEGF levels in those with liver metastasis were higher than those without liver metastasis(P0.05);and VEGF levels in patients with TNM stage Ⅰ,Ⅱ,Ⅲ and Ⅳ were(120.14±25.88),(192.07±26.95),(77.93±63.18)and(433.40±48.39)pg/ml,respectively(F=83.11,P0.05).Conclusion Serum VEGF levels are increased in patients with colorectal cancer and related to lymph node metastasis,liver metastasis and TNM stages,indicating it might be used as a biomarker for colorectal cancer.
Key concepts: Colorectal cancer, Medicine, Clinical significance, Metastasis, Internal medicine, Biomarker, Stage (stratigraphy), Vascular endothelial growth factor